3 results on '"Wang, Yun F."'
Search Results
2. Time to Sputum Culture Conversion and Treatment Outcomes Among Patients with Isoniazid-Resistant Tuberculosis in Atlanta, Georgia.
- Author
-
Schechter, Marcos C., Bizune, Destani, Kagei, Michelle, Machaidze, Mamuka, Holland, David P., Oladele, Alawode, Wang, Yun F., Rebolledo, Paulina A., Ray, Susan M., and Kempker, Russell R.
- Subjects
DRUG therapy for tuberculosis ,FLUOROQUINOLONES ,CONFIDENCE intervals ,DRUG resistance in microorganisms ,ISONIAZID ,LONGITUDINAL method ,MICROBIAL sensitivity tests ,MULTIVARIATE analysis ,PROBABILITY theory ,SPUTUM ,STATISTICS ,TREATMENT effectiveness ,PROPORTIONAL hazards models ,RETROSPECTIVE studies ,DESCRIPTIVE statistics ,ODDS ratio ,THERAPEUTICS - Abstract
Background. Although isoniazid-resistant tuberculosis is more common than multidrug-resistant tuberculosis, it has been much less studied. We examined the impact of isoniazid resistance and treatment regimen, including use of a fluoroquinolone, on clinical outcomes. Methods. A retrospective cohort study among patients with sputum culture-positive tuberculosis was performed. Early fluoroquinolone (FQ) use was defined as receiving ≥5 doses during the first month of treatment. The primary outcome was time to sputum culture conversion (tSCC). A multivariate proportional hazards model was used to determine the association of isoniazid resistance with tSCC. Results. Among 236 patients with pulmonary tuberculosis, 59 (25%) had isoniazid resistance. The median tSCC was similar for isoniazid-resistant and -susceptible cases (35 vs 29 days; P = .39), and isoniazid resistance was not associated with tSCC in multivariate analysis (adjusted hazard ratio = 0.83; 95% confidence interval [CI], .59-1.17). Early FQ use was higher in isoniazid-resistant than -susceptible cases (20% vs 10%; P = .05); however, it was not significantly associated with tSCC in univariate analysis (hazard ratio = 1.48; 95% CI, .95-2.28). Patients with isoniazid-resistant tuberculosis were treated with regimens containing rifampin, pyrazinamide, and ethambutol +/- a FQ for a median of 9.7 months. Overall, 191 (83%) patients were cured. There was no difference in initial treatment outcomes; however, all cases of acquired-drug resistance (n = 1) and recurrence (n = 3) occurred among patients with isoniazid-resistant tuberculosis. Conclusions. There was no significant association with isoniazid resistance and tSCC or initial treatment outcomes. Although patients with isoniazid-resistant tuberculosis had a high cure rate, the cases of recurrence and acquired drug resistance are concerning and highlight the need for longer-term follow-up studies. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
3. Bloodstream Infections in Children With Sickle Cell Disease: 2010-2019.
- Author
-
Yee, Marianne E., Lai, Kristina W., Bakshi, Nitya, Grossman, Joanna K., Jaggi, Preeti, Mallis, Alexander, Wang, Yun F., Jerris, Robert C., Lane, Peter A., and Yildirim, Inci
- Subjects
- *
BACTERIAL disease prevention , *ANTIBIOTICS , *BLOOD , *ESCHERICHIA coli , *BORDETELLA , *CATHETER-related infections , *IMMUNIZATION , *CELL culture , *CONFIDENCE intervals , *BACTERIAL contamination , *MULTIVARIATE analysis , *BLOOD transfusion , *HYDROXYUREA , *RETROSPECTIVE studies , *STREPTOCOCCAL diseases , *RISK assessment , *HAEMOPHILUS influenzae , *DESCRIPTIVE statistics , *STAPHYLOCOCCUS aureus , *SALMONELLA , *GENOTYPES , *LOGISTIC regression analysis , *ODDS ratio , *SICKLE cell anemia , *BLOODBORNE infections , *LONGITUDINAL method , *DISEASE risk factors , *DISEASE complications , *CHILDREN - Abstract
BACKGROUND: Children with sickle cell disease (SCD) are at increased risk for bloodstream infections (BSIs), mainly because of functional asplenia. Immunizations and antibiotic prophylaxis have reduced the prevalence of invasive bacterial infections, but contemporary analysis of BSI in children with SCD is limited. METHODS: We conducted a retrospective cohort study of children aged <18 years with SCD who had blood cultures collected at our institution from 2010 to 2019 to identify BSI. Probable contaminant organisms were identified and not included as BSI. We calculated the annual incidence of BSI at our institution with 95% confidence intervals (CIs) and used multivariate logistic regression to evaluate associations. RESULTS: There were 2694 eligible patients with 19 902 blood cultures. Excluding repeated cultures and contaminant cultures, there were 156 BSI episodes in 144 patients. The median age at BSI was 7.5 years. The average incidence rate of BSI was 0.89 per 100 person-years (95% CI 0.45--1.32). The most common pathogens were Streptococcus pneumoniae (16.0%), Streptococcus viridans group (9.0%), Escherichia coli (9.0%), Staphylococcus aureus (7.7%), Bordetella holmesii (7.7%), Haemophilus influenzae (7.1%), and Salmonella species (6.4%). Odds of BSI were higher with sickle cell anemia genotypes (odds ratio [OR] 1.88; 95% CI 1.20--2.94) and chronic transfusions (OR 2.66; 95% CI 1.51--4.69) and lower with hydroxyurea (OR 0.57; 95% CI 0.39--0.84). CONCLUSIONS: BSI remains a risk for children with SCD. Overall incidence, risk factors, and spectrum of pathogens are important considerations to guide prevention and empirical treatment of suspected infection in SCD. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.